Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000945234-09-000131
Filing Date
2009-07-13
Accepted
2009-07-13 17:27:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 o56223sv3za.htm S-3/A 235960
2 EX-23.1 o56223exv23w1.htm EX-23.1 2097
3 GRAPHIC o56223o5622300.gif GRAPHIC 1249
  Complete submission text file 0000945234-09-000131.txt   241403
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-160251 | Film No.: 09942529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances